AHSNs Support Implementation of Mobile ECG Devices to Reduce Atrial Fibrillation-Related Stroke

Mobile ECG devices are being funded by NHS England to support the national programme to reduce atrial fibrillation (AF) related stroke.

The programme is being supported by the Academic Health Science Networks (AHSNs) and runs alongside NHS England’s Innovation and Technology Tariff (ITT). A toolkit has been created to help implement the mobile ECG device AliveCorKardia which helps detect AF.

The ITT, which is also being supported by the AHSNs, was introduced by NHS England on 01 April 2017 to incentivise the adoption of innovation in the NHS. Through the Tariff, Innovations are funded by NHS England based on a reimbursement model or the number of uses. For example, care providers can order eligible innovations directly from the supplier at no cost then NHS England will reimburse the supplier directly.

NHS England has recently issued ITT technical notes which offer guidance for commissioners and providers on the themes, specifications, reimbursement and reporting requirements.

Implementation toolkits are also available for four innovations which meet the ITT’s specifications:

If you are interested in developing your AF pathway using mobile ECG devices, please email stuart.monk@swahsn.com

For more information about the ITT funding models and the innovations the SW AHSN will be supporting, click here

You may also be Interested in

AHSN Network supported companies generate £455 million of UK investment  

AHSN Network supported companies generate £455 million of UK investment  

Read more
New funding & vacancy to grow South West mental health equity research

New funding & vacancy to grow South West mental health equity research

Read more
BLOG: Spreading innovation in health & care – why context matters

BLOG: Spreading innovation in health & care – why context matters

Read more
Newsletter

Stay up to date

Sign up to our newsletter for all the latest news and events